WallStreetZenWallStreetZen

NASDAQ: GNLX
Genelux Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GNLX

Based on 1 analyst offering 12 month price targets for Genelux Corp

Min Forecast
$20.00+693.65%
Avg Forecast
$20.00+693.65%
Max Forecast
$20.00+693.65%

Should I buy or sell GNLX stock?

Based on 1 analyst offering ratings for Genelux Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GNLX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates GNLX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their GNLX stock forecasts and price targets.

GNLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-20

1 of 1

Forecast return on equity

Is GNLX forecast to generate an efficient return?

Company
203.36%
Industry
16.48%
Market
167.41%
GNLX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GNLX forecast to generate an efficient return on assets?

Company
125.04%
Industry
23.52%
GNLX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GNLX earnings per share forecast

What is GNLX's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.84
Avg 2 year Forecast
-$0.76
Avg 3 year Forecast
$0.12

GNLX revenue forecast

What is GNLX's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$10.4M
Avg 3 year Forecast
$142.7M

GNLX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNLX$2.52$20.00+693.65%Buy
PMN$12.90$47.80+270.54%Strong Buy
NAUT$0.92N/AN/A
TLSA$0.98$7.00+617.95%Strong Buy
GUTS$0.69$6.67+870.45%Strong Buy
View Top Biotech Stocks

Genelux Stock Forecast FAQ

Is Genelux Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GNLX) stock is to Buy GNLX stock.

Out of 1 analyst, 0 (0%) are recommending GNLX as a Strong Buy, 1 (100%) are recommending GNLX as a Buy, 0 (0%) are recommending GNLX as a Hold, 0 (0%) are recommending GNLX as a Sell, and 0 (0%) are recommending GNLX as a Strong Sell.

If you're new to stock investing, here's how to buy Genelux stock.

What is GNLX's earnings growth forecast for 2026-2028?

(NASDAQ: GNLX) Genelux's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.25%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.98%.

Genelux's earnings in 2026 is -$35,596,000.On average, 8 Wall Street analysts forecast GNLX's earnings for 2026 to be -$37,843,198, with the lowest GNLX earnings forecast at -$40,349,790, and the highest GNLX earnings forecast at -$36,580,853. On average, 7 Wall Street analysts forecast GNLX's earnings for 2027 to be -$34,427,175, with the lowest GNLX earnings forecast at -$40,793,194, and the highest GNLX earnings forecast at -$26,604,257.

In 2028, GNLX is forecast to generate $5,307,278 in earnings, with the lowest earnings forecast at -$43,897,024 and the highest earnings forecast at $77,437,391.

What is GNLX's revenue growth forecast for 2026-2028?

(NASDAQ: GNLX) Genelux's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.45%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.33%.

Genelux's revenue in 2026 is $0.On average, 8 Wall Street analysts forecast GNLX's revenue for 2026 to be $0, with the lowest GNLX revenue forecast at $0, and the highest GNLX revenue forecast at $0. On average, 8 Wall Street analysts forecast GNLX's revenue for 2027 to be $469,465,596, with the lowest GNLX revenue forecast at $0, and the highest GNLX revenue forecast at $802,516,507.

In 2028, GNLX is forecast to generate $6,456,961,758 in revenue, with the lowest revenue forecast at $2,406,599,369 and the highest revenue forecast at $16,589,654,531.

What is GNLX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: GNLX) forecast ROA is 125.04%, which is higher than the forecast US Biotechnology industry average of 23.52%.

What is GNLX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GNLX price target, the average GNLX price target is $20.00, with the highest GNLX stock price forecast at $20.00 and the lowest GNLX stock price forecast at $20.00.

The Wall Street analyst predicted that Genelux's share price could reach $20.00 by Mar 20, 2027. The average Genelux stock price prediction forecasts a potential upside of 693.65% from the current GNLX share price of $2.52.

What is GNLX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: GNLX) Genelux's current Earnings Per Share (EPS) is -$0.86. On average, analysts forecast that GNLX's EPS will be -$0.84 for 2026, with the lowest EPS forecast at -$0.89, and the highest EPS forecast at -$0.81. On average, analysts forecast that GNLX's EPS will be -$0.76 for 2027, with the lowest EPS forecast at -$0.90, and the highest EPS forecast at -$0.59. In 2028, GNLX's EPS is forecast to hit $0.12 (min: -$0.97, max: $1.71).

What is GNLX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: GNLX) forecast ROE is 203.36%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.